PLK1 and central nervous system cancer: As shown in Fig. 1A–C, results of the TCGA database analysis showed that PLK1 mRNA expression was significantly higher in the GBM tissues than in the normal tissues, and PLK1 had the highest level of expression in patients with World Health Organization (WHO) grade IV glioma and GBM.